PSI Advisors’s Fulgent Genetics FLGT Stock Holding History

PSI Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$1.69K	–	298
2025 Q1	$1.69K	Hold	100	–	–	﹤0.01%	612
2024 Q4	$1.85K	Hold	100	–	–	﹤0.01%	737
2024 Q3	$2.17K	Hold	100	–	–	﹤0.01%	734
2024 Q2	$1.96K	Hold	100	–	–	﹤0.01%	719
2024 Q1	$2.17K	Hold	100	–	–	﹤0.01%	662
2023 Q4	$2.89K	Hold	100	–	–	﹤0.01%	691
2023 Q3	$2.67K	Hold	100	–	–	﹤0.01%	673
2023 Q2	$3.7K	Hold	100	–	–	﹤0.01%	618
2023 Q1	$3.12K	Hold	100	–	–	﹤0.01%	577
2022 Q4	$2.98K	Hold	100	–	–	﹤0.01%	571
2022 Q3	$4K	Hold	100	–	–	﹤0.01%	552
2022 Q2	$5K	Hold	100	–	–	﹤0.01%	563
2022 Q1	$6K	Hold	100	–	–	﹤0.01%	532
2021 Q4	$10K	Hold	100	–	–	﹤0.01%	496
2021 Q3	$9K	Buy	+100	New	+$9.09K	﹤0.01%	504

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PSI Advisors's FLGT Position: Q2 2025 in Review

PSI Advisors sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 100 shares — an estimated $1.69K sold.

PSI Advisors first reported a position in FLGT in Q3 2021 and held it in 15 quarters. The position peaked at $10K in Q4 2021. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

PSI Advisors reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
PSI Advisors sold 100 Fulgent Genetics shares in Q2 2025, an estimated $1.69K.
PSI Advisors first reported a position in Fulgent Genetics in Q3 2021 and held it in 15 quarters.
PSI Advisors's Fulgent Genetics position peaked at $10K in Q4 2021.
167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.